Hepatic plasmacytosis as a manifestation of relapse in multiple myeloma treated with thalidomide

Southern Medical Journal

Volumn 98, Issue 2, 2005, Pages 238-240

  Del Giglio, Auro ^a,b   Weinschenker, Patricia ^a   De Araújo Burgos Manhani, Ana Rita ^a   Ippolito Carbonell, Ana Lucia ^a   Mitteldorf, Cristina A T S ^a  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b NONE   (Brazil)

Author keywords

Liver neoplasms; Myeloma; Plasmacytoma; Thalidomide

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERFERON; MELPHALAN; PAMIDRONIC ACID; THALIDOMIDE; VINCRISTINE; ZOLEDRONIC ACID;

ADULT; ARTICLE; ASTHENIA; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; BRADYCARDIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOTHYROIDISM; LIVER BIOPSY; LIVER TUMOR; MULTIPLE MYELOMA; PERCUTANEOUS BIOPSY; PLASMACYTOSIS; SYNCOPE; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; ASTHENIA; BIOPSY; BONE MARROW CELLS; BORONIC ACIDS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MULTIPLE MYELOMA; PLASMA CELLS; PLASMACYTOMA; PYRAZINES; RECURRENCE; THALIDOMIDE;

EID: 14044260591     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000152542.36111.6F     Document Type: Article

References (13)

1. Dimopoulos MA, Anagnostopoulos A, Weber D. Treatment of plasma cell dyscrasias with thalidomide and its derivatives. J Clin Oncol 2003; 21:4444-4454.
2. Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999;341:1565-1571.
3. Avigdor A, Raanani P, Levi I, et al. Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma. Leuk Lymphoma 2001;42:683-687.
4. Yagci M, Sucak GT, Akyol G, et al. Hepatic failure due to CD3+ plasma cell infiltration of the liver in multiple myeloma. Acta Haematol 2002;107:38-42.
5. Mitchell DG, Hill MC. Obstructive jaundice due to multiple myeloma of the pancreatic head: CT evaluation. J Comput Assist Tomogr 1985;9: 1118-1119.
6. Lake G, Schade RR, Van Thiel DH. Extrahepatic biliary tract obstruction due to plasmacytoma. J Clin Gastroenterol 1983;5:273-276.
7. Okabe M, Choi GH, Kudo M, et al. Hepatic failure due to myeloma-associated amyloidosis. J Gastroenterol 1998;33:926-927.
8. Ales NC, Daniels JT, Frizell ER, et al. Multiple myeloma-associated amyloidosis manifested as fulminant hepatic failure. South Med J 2001; 94:1036-1038.
9. Weichhold W, Labouyrie E, Merlio JP, et al. A primary medullary plasmacytoma of the liver: a case report. Am J Surg Pathol 1995;19: 1197-1202.
10. Petrucci MT, Tirindelli MC, De Muro M, et al. Extramedullary liver plasmacytoma: a rare presentation. Leuk Lymphoma 2003;44:1075-1076.
11. Ng P, Slater S, Radvan G, et al. Hepatic plasmacytomas: case report and review of imaging features. Australas Radiol 1999;43:98-101.
12. Demirhan B, Sokmensuer C, Karakayali H, et al. Primary extramedullary plasmacytoma of the liver. J Clin Pathol 1997;50:74-76.
13. Richardson PG, Barlogie B, Berenson J, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003;348: 2609-2617.